160 related articles for article (PubMed ID: 25374103)
1. Carboxy terminus heat shock protein 70 interacting protein reduces tau-associated degenerative changes.
Saidi LJ; Polydoro M; Kay KR; Sanchez L; Mandelkow EM; Hyman BT; Spires-Jones TL
J Alzheimers Dis; 2015; 44(3):937-47. PubMed ID: 25374103
[TBL] [Abstract][Full Text] [Related]
2. U-box protein carboxyl terminus of Hsc70-interacting protein (CHIP) mediates poly-ubiquitylation preferentially on four-repeat Tau and is involved in neurodegeneration of tauopathy.
Hatakeyama S; Matsumoto M; Kamura T; Murayama M; Chui DH; Planel E; Takahashi R; Nakayama KI; Takashima A
J Neurochem; 2004 Oct; 91(2):299-307. PubMed ID: 15447663
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species.
Dickey CA; Yue M; Lin WL; Dickson DW; Dunmore JH; Lee WC; Zehr C; West G; Cao S; Clark AM; Caldwell GA; Caldwell KA; Eckman C; Patterson C; Hutton M; Petrucelli L
J Neurosci; 2006 Jun; 26(26):6985-96. PubMed ID: 16807328
[TBL] [Abstract][Full Text] [Related]
4. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation.
Petrucelli L; Dickson D; Kehoe K; Taylor J; Snyder H; Grover A; De Lucia M; McGowan E; Lewis J; Prihar G; Kim J; Dillmann WH; Browne SE; Hall A; Voellmy R; Tsuboi Y; Dawson TM; Wolozin B; Hardy J; Hutton M
Hum Mol Genet; 2004 Apr; 13(7):703-14. PubMed ID: 14962978
[TBL] [Abstract][Full Text] [Related]
5. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.
Shimura H; Schwartz D; Gygi SP; Kosik KS
J Biol Chem; 2004 Feb; 279(6):4869-76. PubMed ID: 14612456
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane Upregulates the Heat Shock Protein Co-Chaperone CHIP and Clears Amyloid-β and Tau in a Mouse Model of Alzheimer's Disease.
Lee S; Choi BR; Kim J; LaFerla FM; Park JHY; Han JS; Lee KW; Kim J
Mol Nutr Food Res; 2018 Jun; 62(12):e1800240. PubMed ID: 29714053
[TBL] [Abstract][Full Text] [Related]
7. CHIP-ping away at tau.
Goryunov D; Liem RK
J Clin Invest; 2007 Mar; 117(3):590-2. PubMed ID: 17332887
[TBL] [Abstract][Full Text] [Related]
8. In vivo evidence of CHIP up-regulation attenuating tau aggregation.
Sahara N; Murayama M; Mizoroki T; Urushitani M; Imai Y; Takahashi R; Murata S; Tanaka K; Takashima A
J Neurochem; 2005 Sep; 94(5):1254-63. PubMed ID: 16111477
[TBL] [Abstract][Full Text] [Related]
9. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
10. CHIP and HSPs interact with beta-APP in a proteasome-dependent manner and influence Abeta metabolism.
Kumar P; Ambasta RK; Veereshwarayya V; Rosen KM; Kosik KS; Band H; Mestril R; Patterson C; Querfurth HW
Hum Mol Genet; 2007 Apr; 16(7):848-64. PubMed ID: 17317785
[TBL] [Abstract][Full Text] [Related]
11. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.
Pérez MJ; Vergara-Pulgar K; Jara C; Cabezas-Opazo F; Quintanilla RA
Mol Neurobiol; 2018 Feb; 55(2):1004-1018. PubMed ID: 28084594
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphorylated truncated protein tau induces caspase-3 independent apoptosis-like pathway in the Alzheimer's disease cellular model.
Zilkova M; Zilka N; Kovac A; Kovacech B; Skrabana R; Skrabanova M; Novak M
J Alzheimers Dis; 2011; 23(1):161-9. PubMed ID: 20966551
[TBL] [Abstract][Full Text] [Related]
13. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
14. Carboxyl terminus of heat-shock cognate 70-interacting protein degrades tau regardless its phosphorylation status without affecting the spatial memory of the rats.
Zhang YJ; Xu YF; Liu XH; Li D; Yin J; Liu YH; Chen XQ; Wang JZ
J Neural Transm (Vienna); 2008; 115(3):483-91. PubMed ID: 18301957
[TBL] [Abstract][Full Text] [Related]
15. Tau overexpression inhibits cell apoptosis with the mechanisms involving multiple viability-related factors.
Wang HH; Li HL; Liu R; Zhang Y; Liao K; Wang Q; Wang JZ; Liu SJ
J Alzheimers Dis; 2010; 21(1):167-79. PubMed ID: 20413892
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
17. Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP).
Narayan V; Landré V; Ning J; Hernychova L; Muller P; Verma C; Walkinshaw MD; Blackburn EA; Ball KL
Mol Cell Proteomics; 2015 Nov; 14(11):2973-87. PubMed ID: 26330542
[TBL] [Abstract][Full Text] [Related]
18. Notch-induced E2A degradation requires CHIP and Hsc70 as novel facilitators of ubiquitination.
Huang Z; Nie L; Xu M; Sun XH
Mol Cell Biol; 2004 Oct; 24(20):8951-62. PubMed ID: 15456869
[TBL] [Abstract][Full Text] [Related]
19. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances.
Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B
Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801
[TBL] [Abstract][Full Text] [Related]
20. Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation.
Cook C; Gendron TF; Scheffel K; Carlomagno Y; Dunmore J; DeTure M; Petrucelli L
Hum Mol Genet; 2012 Jul; 21(13):2936-45. PubMed ID: 22492994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
